Search

Search Constraints

You searched for: Author/Creator Temam, Stephane

Search Results

1. Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy. (2nd September 2017)

2. Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role?. (August 2016)

3. Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role?. (August 2016)

4. Ewing's Sarcoma of the Head and Neck: Margins are not just for surgeons. (17th November 2018)

5. Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer. Issue 1 (11th November 2021)

6. Head and neck Ewing sarcoma: French surgical practice analysis pleads for surgery centralization. Issue 5 (May 2022)

7. Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma. Issue 3 (4th December 2019)

8. Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy or chemoradiotherapy alone in locally advanced non-endemic nasopharyngeal carcinoma. (November 2016)

9. Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy. (January 2019)

10. Oropharyngeal cancer: First relapse description and prognostic factor of salvage treatment according to p16 status, a GETTEC multicentric study. (January 2021)